Cytology Specimen Collection Procedure
OtherCorrelative studies
Other names: Cytologic Sampling
NCT Number: NCT00899275
The purpose of this study is to collect and store samples of blood and tumor tissue from patients with osteosarcoma. Collecting and storing samples of tumor tissue and blood from patients to test in the laboratory may help the study of cancer in the future.
Looking for future studies?
Notify MeAll sexes
Observational
Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
OBJECTIVES:
I. To collect biological specimens from patients with osteosarcoma at Children?s Oncology Group (COG) institutions.
II. To provide a repository for long-term storage of osteosarcoma-related biological materials.
III. To make these specimens available to qualified researchers to understand the biology of osteosarcoma and correlate these results with the patients' clinical data.
OUTLINE:
After the initial submission of blood samples, patients may undergo open or closed biopsy in order to obtain fresh and frozen tissue samples as well as paraffin embedded material. Patients who are enrolled at the time of initial diagnosis but then have a definitive surgery or develop recurrent disease may submit additional samples (paraffin block, frozen and fresh tumor tissue, or slides together with blood samples). Autopsy tumor samples may also be submitted.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Correlative studies
Other names: Cytologic Sampling
Time frame: Baseline
Children's Oncology Group
Network
A Children?s Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03006848
Neoplasms, Neoplasms by Histologic Type
Los Angeles, California, United States
View Trial DetailsNCT03960177
Neoplasms, Neoplasms by Histologic Type
Jacksonville, Florida, United States
View Trial DetailsNCT04833582
Neoplasms, Neoplasms by Histologic Type
Los Angeles, California, United States
View Trial DetailsNCT02945800
Disease Attributes, Ewing Sarcoma
Birmingham, Alabama, United States
View Trial Details